Sumita Ray

Sumita Ray, J.D. has served as a member of the board of directors since June, 2021. Ms. Ray serves as Chief Legal and Administrative Officer at Calithera Biosciences, Inc. (NASDAQ: CALA). Prior to joining Calithera, Ms. Ray served on the Executive Management Team of Pharmacyclics, as Chief Compliance Officer and Associate General Counsel, Head of Healthcare and Regulatory Law, until its acquisition by Abbvie. Prior to Pharmacyclics, she served in leadership roles as in-house counsel for Elan Pharmaceuticals, Genentech and AstraZeneca. Ms. Ray started her legal career as a litigator at Montgomery, McCracken, Walker and Rhoads LLP. Ms. Ray has more than 20 years of life science, pharmaceutical and biotechnology experience, spanning private practice and in-house legal and operational roles in various therapeutic areas including Oncology, Neurology and Primary Care. She has legal expertise in FDA regulatory law, global health care law, compliance, privacy, brand support, product launches, collaborations and alliance management, as well as extensive experience leading and managing business functions in these industries. Ms. Ray holds a Juris Doctor from Temple University School of Law and a Bachelor of Science in Microbiology with a minor in Chemistry from the University of Arizona. We believe that Ms. Ray is qualified to serve on our board of directors due to her extensive legal background and experience as a senior executive in biotechnology and pharmaceutical companies.